Priya Sumithran

Endocrinologist. Obesity researcher. Human.

[Sarah Melton @sarahlmelton]

That’s a wrap on #GastroDiet2025 @MonashFODMAP 🇮🇹

Loved presenting on the role of dietitians as leaders of GI services and our roundtable session on weight loss strategies with A/Prof @psumithran1

[The Lancet Diabetes & Endocrinology @TheLancetEndo]

Priya Sumithran & Louise A Baur comment on:
Growing evidence for semaglutide efficacy in Asian adults with obesity https://t.co/ikLxxl2kaI
#obesity

[Ted Kyle @ConscienHealth]

At the #OW2024 opening last night, @BrocqSarah totally nailed it:
“We offer acute treatment for a chronic condition and that simply does not work.”

https://t.co/kjf4hmEh6a

[The Lancet @TheLancet]

Obesity is a growing global epidemic with major health consequences.

Bariatric surgery is the most effective treatment, with progress in the development of pharmacological agents. However, all obesity treatments have been underutilised.

Find out more:
https://t.co/97Ccllbwfe

[Lotte Bjerre Knudsen @lotte_bjerre]

GLP-1 for Treating Obesity: 2024 Lasker-DeBakey Clinical Medical Research Award https://t.co/U4029HwEjc

[The Lancet @TheLancet]

Obesity is a growing epidemic with major health consequences.

"It is crucial to enhance prevention efforts and explore effective interventions that are scalable irrespective of sociodemographic considerations", say authors of a Seminar.

Read this & more: https://t.co/Cqb1eicHQ1

[Ali Aminian @Ali_Aminian_MD]

Published today in @TheLancet

Management of #obesity follows the same principles as management of other CHRONIC conditions.

https://t.co/aBqjLI6Rv5

[Daniel J Drucker @DanielJDrucker]

Newsflash. 99% of all chronic disorders relapse after stopping medical therapy

[Priya Sumithran @psumithran1]

@drvyom Indian bingo. Happy Diwali!

[Ted Kyle @ConscienHealth]

#SELECTstudy is out in @NEJM and at #AHA23 today. It's pretty much unmistakable now that obesity treatment can help people lead longer, healthier lives. Time has come to tear down the barriers to equitable access to care.
HT: @ObesityAction @MarsApovian
https://t.co/h2u29YatQ1

[Bariatric Surgery Registry @Bariatric_CQR]

Are you undergoing #bariatric (weight-loss) surgery or hiatus hernia repair in Australia?

Participate in @Bariatric_CQR #research to understand how surgery affects your #mood, #qualityoflife, and eating behaviour.

Follow the link to learn more: https://t.co/TWgpeHMMts

[The Lancet @TheLancet]

"The impact of obesity on morbidity, mortality, quality of life, and health-care costs is immense—we cannot afford not to treat it from a health, economic, or ethical perspective."

New Comment—Obesity drug shortages are symptomatic of wider malaise: https://t.co/23yncM15aY

[David Arterburn, MD, MPH @davearterburn]

Obesity drug shortages are symptomatic of wider malaise - @psumithran1 @rvcohen @FrancisFinucane https://t.co/I4ayXYkgl3

[Ted Kyle @ConscienHealth]

Yes, we're making progress in overcoming #obesity. But no, we're not yet ready to take it seriously as a #ChronicDisease.
New insight from @RVCohen @PSumithran @FrancisFinucane @IanPatton55 @xramossalas et al.
https://t.co/SbTPXDWUvB

[stephen o'rahilly (its pronounced O-RA-hill-EEE) @StephenORahilly]

https://t.co/yRvD2PmJIa How do we get across the simple idea that if people are real experts in an area they will be asked to advise industry?

[Matthias Tschöp @MatthiasTschop]

Her work paved the way for blockbuster obesity drugs. Now, she’s fighting for recognition | Science | AAAS https://t.co/c8tVHCRwWc

[Jen Heemstra @jenheemstra]

We can all benefit from having someone who believes in us, and we can each be that person for someone else.

[Priya Sumithran @psumithran1]

@RodolfoJGalindo @ObesitySociety @OMAsocial @TheAACE @TheEndoSociety @BevTchangMD @MichaelAlbertMD @JaimeAlmandoz @askdrfatima @NeilFlochMD @JaimePonceMD @MarsApovian @carel_leroux @DrKarlNadolsky Initial rapid vs gradual makes no difference for weight loss maintenance.
https://t.co/909xsPxNoK
Maintenance will vary depending on intervention/strategy for maintenance

[Jaime Ponce MD @JaimePonceMD]

Is Metabolic Surgery Having an Identity Crisis?
• The answer is “no.”
• Anti-obesity Meds (AOMs) are very effective now (>20% WL)
• Head-to-head studies AOM vs Surgery have not yet been conducted
• Response to AOMs treatment varies:
- With DM can have less response (10%WL)
- With morbid obesity may not be enough
- Adherence long-term may be challenging (cost, etc.)
• SG and RYGB have robust data on efficacy and safety long-term
• Treatment of obesity is not a one-size-fits-all (multi-modal options are needed)
• Surgery remains the most effective and durable anti-obesity intervention
• Surgery still widely underutilized despite large body of evidence (long-term efficacy and safety)
https://t.co/ND1uekMZvY
Great communication @rvcohen